The biotech company Amniotics has developed technologies for extracting and refining amniotic fluid stem cells for cutting-edge therapy methods. In 2020, the company will enter the clinical phase, which may lead to a breakthrough in future cell therapies. https://www.di.se/brandstudio/amniotics/unika-stamceller-ur-fostervatten/
Media & Publications
Researchers at the biotech company Amniotics in Lund has developed a lung specific stem cell for treatment of covid-19. The market for treating lung- and airway diseases is valued at 47 billion Euro. – At present, we are working day and night to finish our process...
Nio projekt för medicin och vaccin mot covid-19 pågår i Medicon Valley. Ett är Amniotics lungspecifika stamceller mot covid-19.
Amniotics™ is currently trying to help the local community as much as possible in the coronavirus crisis. We are donating our protective clothing that we use in our GMP laboratory to Region Skåne. These clothes, designed to minimize spread of particles are only used...
Longboat Amniotics had an article in Dagens Industri (text in Swedish), describing our quick progress and ambitions. https://www.di.se/brandstudio/amniotics/unika-stamceller-ur-fostervatten/
Longboat Amniotics raised SEK 20M in a new investment round in June. The Investment will be used for building a GMP production and further develop the pipeline of tissue specific mesenchymal stem cells. https://lnkd.in/em9KDEshttps://lnkd.in/ePBb_Ca